US Precision Pharmacy
Pharmaceutical ManufacturingCalifornia, United States0-1 Employees
US Precision develops and sells proprietary products for sleep, anxiety, stress, pain and other chronic conditions
Market Niche Focus US Precision Pharmacy specializes in developing proprietary products for sleep, anxiety, stress, pain, and other chronic conditions, indicating an opportunity to target health and wellness retailers, or online health platforms seeking innovative natural or supplement solutions.
Limited Workforce With a small team of fewer than one employee, US Precision may be in early development or outsourcing manufacturing, presenting potential for partnership in supply chain management, distribution, or manufacturing scale-up services.
Digital Presence The company’s website utilizes standard e-commerce and analytics technologies, suggesting a digital-first sales approach that can be expanded through targeted online marketing and customer engagement strategies.
Financial Growth Potential Currently reporting revenue under 1 million dollars with no visible funding, US Precision presents an opportunity for investors or partners interested in early-stage health product companies with growth potential in the wellness market.
Competitive Landscape Operating in a space with large health and pharmacy chains suggests the need for strategic partnerships or distribution agreements to enhance market reach against well-established competitors like CVS, Walgreens, and Rite Aid.
US Precision Pharmacy uses 8 technology products and services including Cart Functionality, jQuery, jQuery UI, and more. Explore US Precision Pharmacy's tech stack below.
| US Precision Pharmacy Email Formats | Percentage |
| FLast@myprecisionpharmacy.com | 100% |
Pharmaceutical ManufacturingCalifornia, United States0-1 Employees
US Precision develops and sells proprietary products for sleep, anxiety, stress, pain and other chronic conditions
US Precision Pharmacy's revenue is estimated to be in the range of $1M
US Precision Pharmacy's revenue is estimated to be in the range of $1M